 Home > Biochemistry News > Biotechnology News > Ascent Pharmaceuticals APG-115 for the treatment of stage IIB-IV melanoma was approved as an orphan drug by the FDA

Ascent Pharmaceuticals APG-115 for the treatment of stage IIB-IV melanoma was approved as an orphan drug by the FDA

 Last Update: 2021-07-27
 Source: Internet
 Author: User

Tags

microdot drug

pharmaceutical careers

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On July 21, Ascent Pharmaceuticals announced that the company’s original innovative drug MDM2-p53 inhibitor APG-115 has been granted Orphan Drug Designation (ODD) by the U.

It is reported that this is the fifth orphan drug designation granted by APG-115 following gastric cancer, acute myeloid leukemia, soft tissue sarcoma, and retinoblastoma

Since 2011, immunotherapy represented by Immune Checkpoint Inhibitors (ICI) has brought unprecedented breakthroughs in the clinical treatment of melanoma

In tumor therapy, p53 gene is one of the most widely studied tumor suppressor genes.

Structure of APG-115

APG-115 is an oral, highly selective inhibitor of MDM2-p53 under development by Ascent Pharmaceuticals.

The data shows that in the cohort of APG-115 combined with pembrolizumab in the treatment of PD-1/PD-L1 inhibitor-resistant melanoma, one patient achieved complete remission (CR), and the objective response rate (ORR) of this cohort It reached 24.

In addition to APG-115, global MDM2 inhibitors are also Roche's pyrrolidine derivatives RG7388, RG7112, Rain Therapeutics' RAIN-32, and Amgen's AMG232

Reference materials:

[1]https://mp.

[2]https://mp.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.